Hepatocellular carcinoma risk quantified in PBC patients
Biochemical nonresponse was the most significant predictor of future risk for developing hepatocellular carcinoma among an international cohort of patients with primary biliary cirrhosis (PBC).
In a...
Source: Family Practice News - Category: Primary Care Source Type: news
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Family Practices | Hepatocellular Carcinoma | Liver Cancer | Primary Biliary Cirrhosis | Primary Care